Madison El-Saadi
Stock Analyst at B. Riley Securities
(1.21)
# 3,685
Out of 5,058 analysts
9
Total ratings
44.44%
Success rate
-4.86%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Madison El-Saadi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VNDA Vanda Pharmaceuticals | Initiates: Buy | $11 | $5.14 | +114.01% | 1 | Nov 5, 2025 | |
| AXSM Axsome Therapeutics | Initiates: Buy | $179 | $146.77 | +21.96% | 1 | Oct 1, 2025 | |
| CAPR Capricor Therapeutics | Initiates: Buy | $21 | $5.77 | +263.95% | 1 | Jun 26, 2025 | |
| ETON Eton Pharmaceuticals | Reiterates: Buy | $24 → $26 | $16.82 | +54.58% | 3 | May 16, 2025 | |
| WVE Wave Life Sciences | Maintains: Buy | $19 → $22 | $6.88 | +219.77% | 3 | Nov 4, 2024 |
Vanda Pharmaceuticals
Nov 5, 2025
Initiates: Buy
Price Target: $11
Current: $5.14
Upside: +114.01%
Axsome Therapeutics
Oct 1, 2025
Initiates: Buy
Price Target: $179
Current: $146.77
Upside: +21.96%
Capricor Therapeutics
Jun 26, 2025
Initiates: Buy
Price Target: $21
Current: $5.77
Upside: +263.95%
Eton Pharmaceuticals
May 16, 2025
Reiterates: Buy
Price Target: $24 → $26
Current: $16.82
Upside: +54.58%
Wave Life Sciences
Nov 4, 2024
Maintains: Buy
Price Target: $19 → $22
Current: $6.88
Upside: +219.77%